| 1 | miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy h-028af077 | miR-33/ABCA1 | validated | 0.824 | 2026-05-16 | Open → |
| 2 | p16^INK4a-CCF Axis as Senolytic Timing Biomarker h-70bc216f06 | CDKN2A, CGAS, STING1 | validated | 0.805 | 2026-05-14 | Open → |
| 3 | p21^Cip1 Phospho-State as Autophagy Responsiveness Predictor h-94ae1e45a0 | CDKN1A, CDK4, CDK6, ATM, PPP1CA | proposed | 0.768 | 2026-05-14 | Open → |
| 4 | APOE4-driven lysosome-to-ER cholesterol transport failure reduces ER-accessible… h-1b47a73770 | NPC1 | proposed | 0.741 | 2026-05-14 | Open → |
| 5 | APOE4 hypolipidation and ABCA1 mistrafficking impair cholesterol efflux and sec… h-bf7edcbc78 | ABCA1 | proposed | 0.694 | 2026-05-14 | Open → |
| 6 | mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker h-82100428d0 | MTOR, RPTOR, RPS6KB1, TSC1, TSC2 | proposed | 0.682 | 2026-05-14 | Open → |
| 7 | GDF15-GFRAL Axis as Systemic Autophagy-Senescence Integrator h-8ef10f60b8 | GDF15, GFRAL, NTRK2 | proposed | 0.659 | 2026-05-14 | Open → |
| 8 | Conserved 5' Terminal Stem-Loop in NORAD Enables ASO-Mediated Restoration of Ge… h-e6ffaba500 | NORAD | proposed | 0.657 | 2026-05-14 | Open → |
| 9 | Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows h-b47073b186 | TFEB, MAPK14, MAPKAPK2, IL6, CXCL1 | proposed | 0.614 | 2026-05-14 | Open → |
| 10 | MALAT1 Three-Way Junction as a Druggable Target for Structure-Selective ASOs h-01eb4f1d71 | MALAT1 | proposed | 0.591 | 2026-05-14 | Open → |
| 11 | Upstream restoration of glial lipid efflux and apoE lipidation will outperform… h-4e823a876a | LXR | proposed | 0.584 | 2026-05-14 | Open → |
| 12 | Multivalent Scaffold Theory: Rif1 SAF Domain Array as High-Valency Condensate C… h-c0c52aec62 | RIF1 | proposed | 0.583 | 2026-05-14 | Open → |
| 13 | ITGAM/CD11b direct binding explains microglial phagocytosis blockade h-b0defed1 | ITGAM | proposed | 0.582 | 2026-05-14 | Open → |
| 14 | Conserved G-Quadruplex Forming Potential in HOTAIR Defines Therapeutic Window h-06d5f49673 | HOTAIR | proposed | 0.568 | 2026-05-14 | Open → |
| 15 | Sticker-Spacer Phase Behavior Determines Recruitment Hierarchy h-15d40f8710 | 53BP1/TP53BP1 | proposed | 0.556 | 2026-05-14 | Open → |
| 16 | Charge-Pattern Asymmetry Creates Electrostatic Recruitment Gates h-23b49dc7d3 | 53BP1/TP53BP1 | proposed | 0.523 | 2026-05-14 | Open → |
| 17 | Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence Gate h-b2fd6e79d1 | NCL, FBL, AMBRA1, CDKN1A | proposed | 0.500 | 2026-05-14 | Open → |
| 18 | Lamin B1 Degradation as Irreversibility Gate h-b97e6bb5f1 | LMNB1, LMNB2, NCOA4, SQSTM1 | proposed | 0.493 | 2026-05-14 | Open → |
| 19 | SREBP-2 Direct Inhibition Hyper-Lipidation Strategy h-var-8c9cecfc00 | SREBF2/ABCA1 | promoted | 0.489 | 2026-05-14 | Open → |
| 20 | C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides for Enhanced APOE4 L… h-var-3993e74fb3 | miR-33a/miR-33b | promoted | 0.489 | 2026-05-14 | Open → |
| 21 | Structured Intronic Scaffold Regions in Enhancer-dilncRNAs Enable Cell-Type Sel… h-a976bf02b0 | ECEPs (PAX6-AS1, KCNC2-AS1) | proposed | 0.489 | 2026-05-14 | Open → |
| 22 | APOE4 Structural Remodeling via HSP70 Chaperone Enhancement Strategy h-var-73142bada1 | HSP70/APOE4 | promoted | 0.486 | 2026-05-14 | Open → |
| 23 | APOE4-associated inflammatory signaling amplifies SREBP2 activity in glia indep… h-1d3f23017e | SREBF2 | proposed | 0.470 | 2026-05-14 | Open → |
| 24 | Tau Conformational Change-Triggered Membrane Disruption hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-1 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 25 | Vesicle Size-Selective Nanobody Penetration hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-7 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 26 | Membrane Curvature-Responsive Cell-Penetrating Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-5 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 27 | Cholesterol Depletion-Targeting Nanobody Vectors hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-4 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 28 | ATP Depletion-Responsive Penetrating Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-6 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 29 | pH-Activated Membrane Fusion Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-2 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 30 | Phosphatidylserine-Targeting Nanobody Chimeras hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-3 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 31 | SREBP-2 Upstream Modulation for APOE4 Lipidation Enhancement h-var-7b37ca6d98 | SREBP-2/SCAP | promoted | 0.453 | 2026-05-14 | Open → |
| 32 | C1q-Alectinib Complexation Disrupts Tight Junction Integrity to Enable Paracell… h-var-ad7d733b0d | CLDN5, OCLN | proposed | 0.445 | 2026-05-14 | Open → |
| 33 | C1q-Targeted miR-33 ASO Delivery for APOE4 Hyper-Lipidation via Microglial Rece… h-var-619379bd14 | miR-33a/miR-33b | promoted | 0.427 | 2026-05-14 | Open → |
| 34 | C1q-Conjugated miR-33 ASO Brain Delivery for Enhanced APOE4 Lipidation h-var-455ea14e8b | miR-33a/miR-33b | promoted | 0.423 | 2026-05-14 | Open → |
| 35 | APOE4 alters the accessible-cholesterol threshold sensed by SCAP through ER mem… h-aadf6dc168 | SCAP | proposed | 0.420 | 2026-05-14 | Open → |
| 36 | C1q-Alectinib Complexation Enhances CNS Penetration via Microglial C1qR-Mediate… h-var-5effbb1a5e | C1QBP | proposed | 0.415 | 2026-05-16 | Open → |
| 37 | A-Tract Bulge Conserved Motifs Enable Selective Targeting of NEAT1 Subdomains h-79f0c46458 | NEAT1 | proposed | 0.413 | 2026-05-14 | Open → |
| 38 | Transferrin-Alectinib Conjugation Enhances Blood-Brain Barrier Transport via Tr… h-var-85632d5906 | TFRC | proposed | 0.406 | 2026-05-16 | Open → |
| 39 | Mitochondrial DNA Release-STING Axis as Senolytic Efficacy Predictor h-var-c4819cffc2 | CGAS, STING1, MT-DNA | proposed | 0.380 | 2026-05-16 | Open → |
| 40 | miR-33 Antisense-Enhanced APOE4 Lipidation as Senolytic Timing Biomarker h-var-3edf3a7706 | miR-33, ABCA1, CDKN2A, CGAS | promoted | 0.380 | 2026-05-16 | Open → |
| 41 | Poorly lipidated APOE4 particles are preferentially routed through LDLR/LRP1 in… h-f4c6f2d080 | LRP1 | proposed | 0.340 | 2026-05-14 | Open → |
| 42 | C1q-Alectinib Complexation Facilitates Brain Penetration via Receptor-Mediated… h-b63c1b4f | C1Q | proposed | 0.161 | 2026-05-14 | Open → |
| 43 | Direct C1q Binding Enables FcγR-Independent Complement Activation on Tumor Cells h-518f3f28 | C1Q | proposed | 0.148 | 2026-05-14 | Open → |
| 44 | Human Serum Albumin-Mediated Displacement Creates False-Positive C1q Binding Si… h-cf4ff89c | C1Q | proposed | 0.132 | 2026-05-14 | Open → |
| 45 | C1q Binding Reflects Broader Kinase Inhibitor Promiscuity Rather Than Specific… h-47441cb2 | C1Q | proposed | 0.124 | 2026-05-14 | Open → |
| 46 | Alectinib Binds Mitochondrial C1q-like Proteins (C1QDC1) Rather Than Circulatin… h-463544b1 | C1Q | proposed | 0.122 | 2026-05-14 | Open → |
| 47 | C1q Binding Analysis Across ALK Inhibitor Chemical Series Would Resolve Specifi… h-d6ae0140 | C1Q | proposed | 0.115 | 2026-05-14 | Open → |
| 48 | Alectinib's Putative C1q Binding Derives from Hydrophobic Aggregation Rather Th… h-df000ab0 | C1Q | proposed | 0.105 | 2026-05-14 | Open → |